The FDA granted zongertinib Breakthrough Therapy Designation for patients with HER2 (ERBB2)-mutant advanced NSCLC as an initial treatment. The FDA also awarded a Commissioner's National Priority ...

Chemistry World provides expert, independent science journalism for the global chemical science community. We are part of the ...

Real-time dynamic image analysis delivers detailed concentration measurements critical for distinguishing stem cell populations from debris.

This press release is not intended for UK mediaHERNEXEOS® (zongertinib tablets) approved based on an objective response rate of 76% (N=72) as ...

IntroductionIn December 2025, Zscaler ThreatLabz discovered a campaign linked to APT37 (also known as ScarCruft, Ruby Sleet, and Velvet Chollima), which is a DPRK-backed threat group. In this campaign ...

Ukraine has been putting up valiant resistance, but its determination cannot disguise the fact that it is losing the war. Russia controls a large swath of Ukrainian territory, and Kyiv has little ...

In the age of AI, the scarcest resource in headquarters is no longer time. It is, rather, the willingness to say no. Artificial intelligence is moving ...

This press release is not intended for UK media HERNEXEOS (zongertinib tablets) approved based on an objective response rate of 76% (N=72) as demonstrated in the Beamion LUNG-1 clinical trial1 Acceler ...

Hope you've been saving your Rocketeer Drivers.

AS the nation celebrates the 40th anniversary of the EDSA People Power Revolution, reflections typically gravitate toward the images of gathered masses and the peaceful transition of power. However, ...

Jupiter Fund Management Plc ( JFHHF) Q4 2025 Earnings Call February 26, 2026 5:00 AM EST ...

In the Phase 2 S-OLARIS clinical trial in axial spondyloarthritis (axSpA), sonelokimab (SLK) demonstrated clinically meaningful benefit with 80+% of patients achieving ASAS40 by Week 12Consistently, ...